Figure 2 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
Larkin JR., Anthony S., Johanssen VA., Yeo T., Sealey M., Yates AG., Smith CF., Claridge TDW., Nicholson BD., Moreland J-A., Gleeson F., Sibson NR., Anthony DC., Probert F.
<p><b>A,</b> Mean NMR spectra for samples from unwell patients with either confirmed solid tumor diagnoses (red, <i>n</i> = 17) or confirmed noncancer diagnoses (black, <i>n</i> = 175). <b>B,</b> Difference spectrum showing regions that were increased in patients with solid tumors (red), decreased in patients with solid tumors (blue), or unchanged (gray). <b>C,</b> Insets showing magnified regions at points of significant difference between unwell with solid tumor spectra (red) and unwell without cancer spectra (black). NAC, <i>N</i>-acetylated glycoproteins.</p>